Literature DB >> 26384569

Multimerization of a Proline-Rich Antimicrobial Peptide, Chex-Arg20, Alters Its Mechanism of Interaction with the Escherichia coli Membrane.

Wenyi Li1, Neil M O'Brien-Simpson2, Julien Tailhades3, Namfon Pantarat4, Raymond M Dawson5, Laszlo Otvos6, Eric C Reynolds2, Frances Separovic7, Mohammed Akhter Hossain8, John D Wade9.   

Abstract

A3-APO, a de novo designed branched dimeric proline-rich antimicrobial peptide (PrAMP), is highly effective against a variety of in vivo bacterial infections. We undertook a selective examination of the mechanism for the Gram-negative Escherichia coli bacterial membrane interaction of the monomer (Chex-Arg20), dimer (A3-APO), and tetramer (A3-APO disulfide-linked dimer). All three synthetic peptides were effective at killing E. coli. However, the tetramer was 30-fold more membrane disruptive than the dimer while the monomer showed no membrane activity. Using flow cytometry and high-resolution fluorescent microscopy, it was observed that dimerization and tetramerization of the Chex-Arg20 monomer led to an alteration in the mechanism of action from non-lytic/membrane hyperpolarization to membrane disruption/depolarization. Our findings show that the membrane interaction and permeability of Chex-Arg20 was altered by multimerization.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26384569     DOI: 10.1016/j.chembiol.2015.08.011

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  17 in total

1.  Combating multidrug-resistant Gram-negative bacteria with structurally nanoengineered antimicrobial peptide polymers.

Authors:  Shu J Lam; Neil M O'Brien-Simpson; Namfon Pantarat; Adrian Sulistio; Edgar H H Wong; Yu-Yen Chen; Jason C Lenzo; James A Holden; Anton Blencowe; Eric C Reynolds; Greg G Qiao
Journal:  Nat Microbiol       Date:  2016-09-12       Impact factor: 17.745

2.  Mode of Action of a Designed Antimicrobial Peptide: High Potency against Cryptococcus neoformans.

Authors:  Aritreyee Datta; Vikas Yadav; Anirban Ghosh; Jaesun Choi; Dipita Bhattacharyya; Rajiv K Kar; Humaira Ilyas; Arkajyoti Dutta; Eunseol An; Jayanta Mukhopadhyay; Dongkuk Lee; Kaustuv Sanyal; Ayyalusamy Ramamoorthy; Anirban Bhunia
Journal:  Biophys J       Date:  2016-10-18       Impact factor: 4.033

3.  C-terminus amidation influences biological activity and membrane interaction of maculatin 1.1.

Authors:  Shiying Zhu; Wenyi Li; Neil O'Brien-Simpson; Frances Separovic; Marc-Antoine Sani
Journal:  Amino Acids       Date:  2021-04-23       Impact factor: 3.520

Review 4.  Recent Advances on Multi-Parameter Flow Cytometry to Characterize Antimicrobial Treatments.

Authors:  Lucie Léonard; Lynda Bouarab Chibane; Balkis Ouled Bouhedda; Pascal Degraeve; Nadia Oulahal
Journal:  Front Microbiol       Date:  2016-08-08       Impact factor: 5.640

5.  The Effect of Selective D- or Nα-Methyl Arginine Substitution on the Activity of the Proline-Rich Antimicrobial Peptide, Chex1-Arg20.

Authors:  Wenyi Li; Zhe Sun; Neil M O'Brien-Simpson; Laszlo Otvos; Eric C Reynolds; Mohammed A Hossain; Frances Separovic; John D Wade
Journal:  Front Chem       Date:  2017-01-19       Impact factor: 5.221

Review 6.  Membrane Active Peptides and Their Biophysical Characterization.

Authors:  Fatma Gizem Avci; Berna Sariyar Akbulut; Elif Ozkirimli
Journal:  Biomolecules       Date:  2018-08-22

7.  Identification, Recombinant Expression, and Characterization of LHG2, a Novel Antimicrobial Peptide of Lactobacillus casei HZ1.

Authors:  Junfang He; Xuegang Luo; Duxin Jin; Yunyang Wang; Tongcun Zhang
Journal:  Molecules       Date:  2018-09-03       Impact factor: 4.411

Review 8.  Physicochemical Features and Peculiarities of Interaction of AMP with the Membrane.

Authors:  Malak Pirtskhalava; Boris Vishnepolsky; Maya Grigolava; Grigol Managadze
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-17

9.  An acidic model pro-peptide affects the secondary structure, membrane interactions and antimicrobial activity of a crotalicidin fragment.

Authors:  Nelson G O Júnior; Marlon H Cardoso; Elizabete S Cândido; Daniëlle van den Broek; Niek de Lange; Nadya Velikova; J Mieke Kleijn; Jerry M Wells; Taia M B Rezende; Octávio Luiz Franco; Renko de Vries
Journal:  Sci Rep       Date:  2018-07-24       Impact factor: 4.379

10.  A Novel Lipopeptaibol Emericellipsin A with Antimicrobial and Antitumor Activity Produced by the Extremophilic Fungus Emericellopsis alkalina.

Authors:  Eugene A Rogozhin; Vera S Sadykova; Anna A Baranova; Alexey S Vasilchenko; Vladislav A Lushpa; Konstantin S Mineev; Marina L Georgieva; Alexander B Kul'ko; Mikhail E Krasheninnikov; Alexey V Lyundup; Anastasia V Vasilchenko; Yaroslav A Andreev
Journal:  Molecules       Date:  2018-10-27       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.